Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sarepta Therapeutics
Sarepta Therapeutics
Four New Drugs are Around the Corner. Here’s What You Need to Know.
Xconomy
Thu, 08/15/19 - 11:39 pm
FDA
drug approvals
AbbVie
Upadacitinib
Exondys 51
Sarepta Therapeutics
Nabriva Therapeutics
lefamulin
Roche
Rozlytrek
Patient in Sarepta gene therapy trial develops serious illness; shares plunge
Yahoo/Reuters
Thu, 08/8/19 - 11:34 pm
Sarepta Therapeutics
Duchenne Muscular Dystrophy
rhabdomyolysis
gene therapy
Studies Show Sarepta's Exondys 51 Slows Respiratory Decline in Muscular Dystrophy Patients
BioSpace
Wed, 07/10/19 - 04:31 pm
Sarepta Therapeutics
Exondys 51
DMD
Duchenne Muscular Dystrophy
UPDATED: Sarepta's Exondys 51 is not cost-effective, nor particularly beneficial for DMD patients — ICER
Endpoints
Thu, 05/23/19 - 10:08 am
Duchenne Muscular Dystrophy
ICER
Sarepta Therapeutics
Exondys 51
These 6 biotech stocks are promising takeover targets
Marketwatch
Thu, 05/2/19 - 11:33 am
M&A
Sarepta Therapeutics
Amarin
Intercept Pharmaceuticals
Immunomedics
Alder Biopharmaceuticals
Biogen
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
Yahoo/Benzinga
Sun, 04/14/19 - 03:57 pm
Wave Life Sciences
Sarepta Therapeutics
Novavax
ContraFect
Scynexis
earnings
Abbott Labs
Intuitive Surgical
Brainsway
Hookipa
Turning Point Therapeutics
IPOs
Sarepta to seek speedy approval of third DMD drug
Biopharma Dive
Thu, 03/28/19 - 07:57 pm
Sarepta Therapeutics
FDA
Duchenne Muscular Dystrophy
casimersen
Gene Therapy Market Heats up as Sarepta Buys Myonexus for $165 Million
BioSpace
Wed, 02/27/19 - 10:57 am
Sarepta Therapeutics
gene therapy
M&A
Myonexus
CRISPR corrects DMD in mice for a year in Sarepta-supported study
Fierce Biotech
Mon, 02/18/19 - 11:29 am
Duke University
Sarepta Therapeutics
CRISPR
gene editing
DMD
Duchenne Muscular Dystrophy
[audio+transcript] 6 Biotech Stocks to Watch Now
Motley Fool
Fri, 02/1/19 - 10:36 pm
Biogen
Bluebird Bio
Global Blood Therapeutics
Aimmune Therapeutics
Vertex Pharmaceuticals
Sarepta Therapeutics
Moment of truth for Sarepta and Myonexus
EP Vantage
Wed, 01/23/19 - 07:49 pm
Sarepta Therapeutics
gene therapy
MYO-101
Limb Girdle Muscular Dystrophy
3 Things You Need to Know About the FDA's Plan for Gene-Editing Drugs
Motley Fool
Sun, 01/20/19 - 10:24 pm
FDA
gene editing
Novartis
Sarepta Therapeutics
CAR-T
Alzheimer's disease
Hunting productivity, drugmakers pitch new 'pillars' of R&D
Biopharma Dive
Sat, 01/12/19 - 11:31 am
R&D
Moderna Therapeutics
Sarepta Therapeutics
Ionis Pharmaceuticals
Six Things to Watch for at the JP Morgan Healthcare Conference
BioSpace
Fri, 01/4/19 - 10:35 am
Moderna Therapeutics
Sarepta Therapeutics
Biogen
Gilead Sciences
Bluebird Bio
Sarepta inks deal to bolster gene therapy manufacturing
Biopharma Dive
Fri, 01/4/19 - 09:06 am
Sarepta Therapeutics
Aldevron
gene therapy
15 For ’19: Key Clinical Data To Watch For Next Year (Part 1)
Xconomy
Mon, 12/17/18 - 09:44 am
clinical trials
Alzheimer's disease
Biogen
Duchenne Muscular Dystrophy
Pfizer
Solid Biosciences
Sarepta Therapeutics
hemophilia A
Biomarin
Multiple Myeloma
Celgene
Bluebird Bio
Amgen
solid tumors
Bristol-Myers Squibb
Nektar Therapeutics
age-related macular degeneration
Regenxbio
SAGE Therapeutics
MorphoSys
Sarepta, AcelRx Look to Infuse Some Cash into Their Pipelines
BioSpace
Sat, 11/10/18 - 12:00 pm
Sarepta Therapeutics
AcelRx
stock offering
Myonexus Therapeutics Starts Trial of First-Ever Gene Therapy for Rare Type of Muscular Dystrophy
CP Wire
Thu, 11/8/18 - 12:11 pm
Myonexus
Sarepta Therapeutics
muscular dystrophy
gene therapy
Myonexus Therapeutics Starts Trial of First-Ever Gene Therapy for Rare Type of Muscular Dystrophy
Thu, 11/8/18 - 09:56 am
Myonexus
Sarepta Therapeutics
muscular dystrophy
Antisense startup Stoke Therapeutics secures another $90M in series B funding
Endpoints
Tue, 10/23/18 - 10:34 am
Stoke Therapeutics
Sarepta Therapeutics
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »